France Alopecia Market Size & Outlook, 2023-2030
France alopecia market, 2018-2030 (US$M)
Related Markets
France alopecia market highlights
- The France alopecia market generated a revenue of USD 353.9 million in 2023 and is expected to reach USD 683.0 million by 2030.
- The France market is expected to grow at a CAGR of 9.8% from 2024 to 2030.
- In terms of segment, pharmaceuticals was the largest revenue generating treatment in 2023.
- Devices is the most lucrative treatment segment registering the fastest growth during the forecast period.
Alopecia market data book summary
| Market revenue in 2023 | USD 353.9 million |
| Market revenue in 2030 | USD 683.0 million |
| Growth rate | 9.8% (CAGR from 2023 to 2030) |
| Largest segment | Pharmaceuticals |
| Fastest growing segment | Devices |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pharmaceuticals, Devices |
| Key market players worldwide | Johnson & Johnson, Cipla Ltd DR, Merck & Co Inc, GlaxoSmithKline, Dr. Reddy’s Laboratories, Aurobindo Pharma, Viatris Inc, Pfizer Inc, Eli Lilly and Co, Curallux, Apira Science, Revance Therapeutics Inc, Theradome, LUTRONIC |
Other key industry trends
- In terms of revenue, France accounted for 4.0% of the global alopecia market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany alopecia market is projected to lead the regional market in terms of revenue in 2030.
- Denmark is the fastest growing regional market in Europe and is projected to reach USD 49.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Alopecia Market Scope
Alopecia Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
France alopecia market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to alopecia market will help companies and investors design strategic landscapes.
Pharmaceuticals was the largest segment with a revenue share of 98.56% in 2023. Horizon Databook has segmented the France alopecia market based on pharmaceuticals, devices covering the revenue growth of each sub-segment from 2018 to 2030.
France is expected to witness significant growth over the forecast period owing to the research initiative focusing on the development of potential treatment in the region and growing awareness in alopecia areata patients.
In addition, it was observed that TNF alpha antagonists, used in treatment of plaque psoriasis, rheumatoid arthritis, inflammatory bowel diseases, and other autoimmune disorders, may cause alopecia.
Increasing prevalence of the aforementioned comorbidities is likely to propel the growth of alopecia market in the near future. In France, the usage of laser devices for alopecia is increasing. There is growth in demand for home-used devices and clinic based laser devices.
Reasons to subscribe to France alopecia market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of France alopecia market databook
-
Our clientele includes a mix of alopecia market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France alopecia market , including forecasts for subscribers. This country databook contains high-level insights into France alopecia market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
France alopecia market size, by treatment, 2018-2030 (US$M)
France Alopecia Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
